Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q1 2026 · 150 positions · Total reported value $2.18B · Top-10 concentration 25.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Invenomic Capital Management LP disclosed 150 equity positions with a combined reported value of $2.18B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 25.3% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q1 2026 were CHRD ($73.23M), WDAY ($72.75M), GPN ($61.55M). By sector, the heaviest allocations are Technology 25.7%, Consumer Discretionary 25.1%. Versus the prior quarter, allocation shifted toward Technology (+8.2pp), Energy (+4.7pp) and away from Industrials (-3.1pp), Materials (-3.2pp).

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions. The portfolio's overlap with the prior quarter was 59% of names.

The largest new positions opened in Q1 2026 were WDAY ($72.75M), HAE ($37.46M), UHS ($33.13M).

Of the 35 positions fully exited versus the prior quarter, the largest were AZO ($54.26M), EQX ($42.51M), CNXC ($36.35M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • WDAY WORKDAY INC · $72.75M
  • HAE HAEMONETICS CORP MASS · $37.46M
  • UHS UNIVERSAL HLTH SVCS INC · $33.13M
  • SOLV SOLVENTUM CORP · $26.20M
  • SPSC SPS COMM INC · $14.70M
  • MNDY MONDAY COM LTD · $13.86M
  • RIVN RIVIAN AUTOMOTIVE INC · $13.39M
  • PRU PRUDENTIAL FINL INC · $11.69M

Fully Exited (vs previous quarter)

  • AZO AUTOZONE INC · prev qtr: $54.26M
  • EQX EQUINOX GOLD CORP · prev qtr: $42.51M
  • CNXC CONCENTRIX CORP · prev qtr: $36.35M
  • DV DOUBLEVERIFY HLDGS INC · prev qtr: $27.27M
  • ORLY OREILLY AUTOMOTIVE INC · prev qtr: $22.73M
  • AIN ALBANY INTL CORP · prev qtr: $19.57M
  • MOS MOSAIC CO · prev qtr: $16.34M
  • BPOP POPULAR INC · prev qtr: $14.34M

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 25.7%
Health Care 18.6%
Industrials 11.5%
Energy 4.7%
Materials 3.2%
Financials 3.0%
Other 3.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 515.08K $73.23M 3.36%
3.36%
Add
2 559.96K $72.75M 3.34%
3.34%
New
3 914.50K $61.55M 2.82%
2.82%
Add
4 763.28K $53.25M 2.44%
2.44%
Add
5 436.12K $52.16M 2.39%
2.39%
Add
6 4.39M $50.93M 2.34%
2.34%
Reduce
7 1.43M $49.22M 2.26%
2.26%
Reduce
8 1.03M $48.51M 2.23%
2.23%
Add
9 405.63K $46.59M 2.14%
2.14%
Reduce
10 3.23M $43.63M 2.00%
2.00%
Reduce
11 223.54K $41.73M 1.92%
1.92%
Add
12 1.03M $39.58M 1.82%
1.82%
Add
13 2.93M $38.93M 1.79%
1.79%
Add
14 424.45K $38.23M 1.75%
1.75%
Add
15 664.73K $37.46M 1.72%
1.72%
New
16 624.99K $34.87M 1.60%
1.60%
Add
17 13.31M $33.67M 1.54%
1.54%
Add
18 447.07K $33.67M 1.54%
1.54%
Reduce
19 950.29K $33.47M 1.54%
1.54%
Reduce
20 185.11K $33.13M 1.52%
1.52%
New
21 934.60K $33.05M 1.52%
1.52%
Add
22 1.38M $32.14M 1.48%
1.48%
Add
23 812.31K $30.21M 1.39%
1.39%
Reduce
24 8.50M $29.82M 1.37%
1.37%
Reduce
25 260.67K $29.37M 1.35%
1.35%
Add
26 1.18M $27.65M 1.27%
1.27%
Reduce
27 1.01M $26.82M 1.23%
1.23%
Add
28 401.16K $26.20M 1.20%
1.20%
New
29 1.43M $25.31M 1.16%
1.16%
Reduce
30 1.76M $25.15M 1.15%
1.15%
Add
31 5.26M $24.20M 1.11%
1.11%
Add
32 439.73K $23.78M 1.09%
1.09%
Reduce
33 1.54M $23.22M 1.06%
1.06%
Add
34 349.39K $23.20M 1.06%
1.06%
Add
35 559.20K $21.54M 0.99%
0.99%
Reduce
36 2.16M $21.33M 0.98%
0.98%
Reduce
37 1.91M $20.98M 0.96%
0.96%
Add
38 3.55M $20.67M 0.95%
0.95%
Add
39 903.46K $20.55M 0.94%
0.94%
Add
40 1.34M $19.64M 0.90%
0.90%
Reduce
41 146.22K $19.30M 0.89%
0.89%
Reduce
42 175.94K $19.04M 0.87%
0.87%
Add
43 1.05M $19.02M 0.87%
0.87%
Add
44 1.96M $18.80M 0.86%
0.86%
Add
45 97.11K $18.18M 0.83%
0.83%
Add
46 1.64M $18.17M 0.83%
0.83%
Add
47 1.93M $16.82M 0.77%
0.77%
Add
48 2.92M $16.58M 0.76%
0.76%
Add
49 2.04M $15.91M 0.73%
0.73%
Reduce
50 2.01M $15.82M 0.73%
0.73%
Add

FAQ

What did Invenomic Capital Management LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Invenomic Capital Management LP reported 150 equity positions worth $2.18B in aggregate; its largest disclosed positions were CHRD ($73.23M), WDAY ($72.75M), GPN ($61.55M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $2.18B of long equity holdings across 150 positions as of 2026-Q1. Top-10 holdings account for 25.3% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →